Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Inhibitor"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
dewey-ones:"610 - Medicine & health"
author_facet:"CADTH Canadian Drug Expert Committee"
Search alternatives
:
inhibitor »
inhibitors
,
inhibition
Showing
1
-
20
of
25
Search:
'"Inhibitor"'
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...
Published 2018
CADTH
Subjects:
“
...HIV Integrase
Inhibitors
/ therapeutic use...
”
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...
Published 2018
CADTH
Subjects:
“
...HIV Integrase
Inhibitors
/ therapeutic use...
”
Read Now
3
CADTH Canadian Drug Expert Committee recommendation: Crisaborole (Eucrisa -- Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patie...
Published 2019
CADTH
Subjects:
“
...Phosphodiesterase 4
Inhibitors
/ therapeutic use...
”
Read Now
4
CADTH Canadian Drug Expert Committee recommendation: Crisaborole (Eucrisa -- Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patie...
Published 2019
CADTH
Subjects:
“
...Phosphodiesterase 4
Inhibitors
/ therapeutic use...
”
Read Now
5
CADTH Canadian drug expert committee recommendation: Upadacitinib (Rinvoq -- abbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthri...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Janus Kinase
Inhibitors
/ therapeutic use...
”
Read Now
6
CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Sodium-Glucose Transporter 2
Inhibitors
/ therapeutic use...
”
Read Now
7
CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Sodium-Glucose Transporter 2
Inhibitors
/ therapeutic use...
”
Read Now
8
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Subjects:
“
...Sodium-Glucose Transporter 2
Inhibitors
/ therapeutic use...
”
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Subjects:
“
...Sodium-Glucose Transporter 2
Inhibitors
/ therapeutic use...
”
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (nitisinone tablets -- Cycle Pharmaceuticals Ltd.) : indication : the treatment of adult and pediatric patients with...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Enzyme
Inhibitors
/ economics...
”
Read Now
11
CADTH Canadian Drug Expert Committee final recommendation: Edoxaban : Lixiana-Servier Canada Inc. : indication : venous thromboembolic events
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Factor Xa
Inhibitors
/ therapeutic use...
”
Read Now
12
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (nitisinone tablets -- Cycle Pharmaceuticals Ltd.) : indication : the treatment of adult and pediatric patients with...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Enzyme
Inhibitors
/ economics...
”
Read Now
13
CADTH Canadian Drug Expert Committee final recommendation: Edoxaban : Lixiana-Servier Canada Inc. : indication : venous thromboembolic events
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Factor Xa
Inhibitors
/ therapeutic use...
”
Read Now
14
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Subjects:
“
...Sodium-Glucose Transporter 2
Inhibitors
/ therapeutic use...
”
Read Now
15
CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2
Published 2019
CADTH
Subjects:
“
...Sodium-Glucose Transporter 2
Inhibitors
/ therapeutic use...
”
Read Now
16
CDEC final recommendation: Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...HIV Integrase
Inhibitors
/ therapeutic use...
”
Read Now
17
CDEC final recommendation: Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...HIV Integrase
Inhibitors
/ therapeutic use...
”
Read Now
18
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...
Published 2019
CADTH
Subjects:
“
...HIV Integrase
Inhibitors
/ therapeutic use...
”
Read Now
19
CADTH Canadian drug expert committee recommendation: Telotristat ethyl (Xermelo -- Ipsen Biopharmaceuticals Canada Inc) : indication : for the treatment of refractory carcinoid syn...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Tryptophan Hydroxylase / antagonists &
inhibitors
...
”
Read Now
20
CADTH Canadian Drug Expert Committee recommendation: Migalastat (Galafold -- Amicus therapeutics) : indication : Fabry disease
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...alpha-Galactosidase / antagonists &
inhibitors
...
”
1
2
Back
Narrow Search
Remove Filters
Clear Filter
Classification: 610 - Medicine & health
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Year of Publication
From:
To:
Classification
610 - Medicine & health
330 - Economics
17
700 - The arts; fine & decorative arts
1
Language
English
25
Collection
National Center for Biotechnology Information
25
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
18
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=dewey-ones%3A%22610+-+Medicine+%26+health%22&filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&lookfor=%22Inhibitor%22&type=Subject
Send by Email
×
Loading...